It is well known that angiotensin II (Angio II) mimics most of the muscarinic-mediated excitatory actions of acetylcholine on superior cervical ganglion neurons. For instance, in addition to depolarization and stimulation of norepinephrine release, muscarinic agonists and Angio II modulate the M-type K + current and the N-type Ca 2+ current. We recently found that muscarinic receptors modulate the delayed rectifier current I KV as well. Therefore, whole-cell patch-clamp was carried out in rat cultured sympathetic neurons to assess whether Angio II modulates I KV . We found that Angio II increased I KV by 30% with a time constant of 30 s. In comparison,
INTRODUCTION
There is growing evidence indicating that an over-activity of the sympathetic nervous system (SNS) contributes to the genesis and maintenance of hypertension (Veerasingham and Raizada 2003) . Blood pressure is long-term regulated by a complex interaction between the SNS and the rennin-angiotensin system, involving feedback mechanisms that in general tend to reinforce their pressor effects. Thus, stimuli such as hypotension or hyposmolality trigger the synthesis of Angio II which directly contracts vascular smooth muscle cells and enhances renal sodium uptake. Besides, circulating Angio II elicits positive feedback on SNS either directly by stimulating norepinephrine (NE) release from sympathetic ganglionic neurons (Boehm and Kubista 2002; Dendorfer et al. 2002) , or via the regulation of several nuclei within the central nervous system (CNS) that regulate sympathetic outflow. For instance, Angio II enhances the firing frequency of action potentials in neurons from the subfornical organ (Ono et al. 2001) , median preoptic nucleus (Bai and Renaud 1998), hypothalamic paraventricular nucleus (Wang et al. 1997) , and pacemaker cells from the rostral ventrolateral medulla, which provide the major excitatory drive to sympathetic preganglionic neurons (Li and Guyenet 1996) .
Little is known on the putative presynaptic mechanisms responsible for facilitation of NE release from postganglionic nerve terminals to sympathetically innervated tissues (Boehm and Kubista 2002) . Most of the stimulatory effects of Angio II might be originated at the somatodendritic membrane of sympathetic ganglionic cells, because the presence of dense specific Angio II binding sites at that cell compartment, as has been shown in neurons from the superior cervical ganglion (SCG) or stellate ganglion (Castrén et al. 1987; Strömberg et al. 1991 ).
Indeed, early microelectrode studies carried out in SCG neurons show that Angio II produces a Page 3 of 37 4 slow membrane depolarization, leading to repetitive spike discharges (Brown et al. 1980) . Therefore, Angio II mimics the strong muscarinic-mediated excitatory action of acetylcholine (ACh) released from the preganglionic motoneuron nerve terminals to sympathetic ganglionic cells (Brown et al. 1980) , suggesting that ACh and Angio II have similar roles regulating the excitability and metabolism of SCG sympathetic neurons. Indeed, Angio II and muscarinic agonists by stimulating AT 1 and M 1 receptors respectively, inhibit both the M-type K + current (M-current) and the N-type Ca 2+ current (I CaN ) (Hamilton et al. 1997; Shapiro et al. 1994; Zaika et al. 2006 ). In addition, stimulation of these receptors activates the inositol phospholipid metabolism (del Rio et al. 1999; Strömberg et al. 1991 ). Recently we found that an M 2/4 muscarinic receptor enhances the SCG delayed rectifier K + current I KV (Cruzblanca 2006) . In view of the close parallelism between the cellular actions of Angio II and muscarinc receptors, we sought here whether I KV was modulated by Angio II. We found that stimulation of the AT 1 receptor enhances I KV current density. Besides, our results suggest that in SCG neurons the AT 1 receptor couples to different signaling pathways to modulate M-current and I KV . Some of these results have appeared in a preliminary form as an abstract (Cruzblanca-Hernandez et al. 2005) .
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METHODS
Cell culture
Electrophysiological experiments were done in cultured SCG neurons taken from juvenile (2-to 4-weeks old) Sprague Dawley or Wistar rats. Neurons were dissociated and cultured following the method by Cruzblanca et al. (1998) . To identify the G subunits expressed by SCG neurons, standard single cell RT-PCR analysis was carried out as indicated in the supporting online material section.
Electrophysiological recording
Whole-cell patch-clamp recordings of I KV , M-current or I CaN were done with a List EPC-7 amplifier and seals were obtained with patch pipettes with 1-2 M resistance. The resulting steady series resistance after 2 min of seal breakthrough was 3-4 M . Voltage command pulses and K + current records were generated and acquired (sampling rate, 5 kHz) using a 12 bit interface (Indec Systems Inc. Sunnyvale, CA). Membrane currents were low-pass filtered at 1 kHz and analyzed using BASIC-FASTLAB (Indec Systems Inc. Sunnyvale, CA) and Sigma Plot (SPSS Inc. Chicago IL) programs. The M-current was recorded with the standard external solution, M-channels were fully activated by setting the holding potential (V h ) at -25 mV and further deactivated by 500 ms pulses from -25 mV to -60 mV, every 4 s. The amplitude of the Mcurrent and its percentage of inhibition were measured as described (Cruzblanca et al. 1998 (Hamilton et al. 1997; Shapiro et al. 1994; Zaika et al. 2006) , and muscarinic agonists enhance the delayed rectifier K + current, I KV (Cruzblanca 2006). Therefore, it might be possible that Angio II modulates I KV as well. Figure 1 shows that Angio II (500 nM) indeed enhanced I KV (A) and, as expected, inhibited M-current (B). In addition to the opposite effects Angio II had on these K + currents, there were additional differences in their latency and rate of modulation (see plots in Figure 1 ). The percentage of I KV mean increase was 30.4 ± 2.4% (n = 15) with a latency of 16.2 ± 0.9 s. As soon as I KV enhancement was detectable this effect developed with a time constant of 29.3 ± 2.8 s. In contrast, M-current mean inhibition was 60.9 ± 3.2% (n = 13) and the effect had a latency and time constant of approximately 8 s and 10.8 ± 0.5 s, respectively. As for I KV muscarinic modulation (Cruzblanca 2006), Angio II produced no changes in the I KV currentvoltage relationship (not shown).
FIGURE 1, HERE
The AT 1 -receptor antagonist losartan reduces the modulation of I KV
To search for the identity of the Angio II receptor type modulating I KV , neurons were treated with the AT 1 -receptor antagonist losartan, 2 min before and throughout peptide exposure.
Initially, I CaN modulation was used as a positive control to verify the potency of losartan (kindly donated by Merck & Co., Inc.) in our experimental conditions since AT 1 receptor inhibits I CaN in 9 SCG cells (Shapiro et al. 1994) . As expected, losartan (2 µM) practically abolished the inhibitory effect of Angio II on I CaN (inset in Figure 2A ). In control cells (n = 5) Angio II produced an I CaN mean inhibition of 40.7 ± 5.7 % (n = 5), whereas in those neurons treated with losartan, this effect was significantly (P < 0.05) reduced to 11.8 ± 0.9% (n = 4). Likewise, losartan remarkably disrupted the I KV enhancement produced by Angio II (Figure 2A ). In summary, the enhancement in I KV current density was reduced by losartan from 10.6 ± 1.5 pA/pF (n = 15) to 3.9 ± 0.8 pA/pF (n = 13). To confirm that an AT 1 receptor was primarily responsible for I KV modulation, a different set of neurons were treated with the AT 2 -selective receptor antagonist PD123319 (2 µM). We found that the mean increase in I KV current density from control and PD123319-treated cells were 11.8 ± 1.9 pA/pF (n = 7) and 11 ± 1.4 pA/pF (n = 13), respectively ( Figure 2B ). Hence I KV modulation by Angio II was quite insensitive to the AT 2 -antagonist.
FIGURE 2, HERE
Modulation of I KV requires the activation of G-proteins of the PTX-insensitive class
Recent evidence indicate that AT 1 receptors can couple directly to signaling molecules different to G-proteins, thereby providing the structural basis for G-protein-independent activation of signaling pathways (Doan et al. 2001; Heuss and Gerber 2000; Seta et al. 2002) . To assess whether or not I KV modulation was linked to the activation of G-proteins, SCG neurons were dialyzed with the G-protein inhibitor GDP--S (2 mM in pipette). GDP--S practically abolished the Angio II-induced I KV enhancement ( Figure 3A , right panel) as compared with those cells dialyzed with the standard GTP-containing pipette internal solution ( Figure 3A , left panel).
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In summary, the increase in I KV current density in neurons dialyzed without and with GDP--S were 10.1 ± 1.6 pA/pF (n = 11) and 2.8 ± 0.8 pA/pF (n = 10), respectively; this difference was statistically significant (P < 0.05).
FIGURE 3, HERE
In many cell types AT 1 receptors commonly couple to G-proteins of the G q family (Alexander et al. 2006 ). However, in some instances this receptor also couples to PTX-sensitive G-proteins to modulate neuronal ion channels (Oz et al. 2002) . Thus, an initial characterization of the G-protein mediating I KV modulation consisted in identifying the G subunits expressed by SCG neurons and in determining the PTX-sensitivity of I KV modulation. Single cell RT-PCR analysis (see methods in the supporting online material) yielded cDNA fragments of the predicted size for the PTX-sensitive G subunits G o , G i1 , G i2 and G i3 and for the PTX-insensitive proteins G q , G 11 , G s , G 12 and G z ( fig. S1 ). Besides, toxin treatment (500 ng/ml) of SCG neurons for 10 h did not disrupt I KV enhancement by Angio II ( Figure 3B ). In summary, Angio II rose I KV current density in control and PTX-treated neurons by 12 ± 1.7 pA/pF (n = 8) and 13.4 ± 0.9 pA/pF (n = 10), respectively. To validate these results we checked for PTX activity in our experimental conditions, by testing the well known PTX-sensitive modulation of I CaN by somatostatin (Beech et al. 1992) . As expected PTX treatment blocked the somatostatin inhibitory effect on I CaN (inset in Figure 3B ).
ATP is required for I KV modulation by Angio II.
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Previously we found that I KV modulation by the muscarinic agonist oxotremorine-M (Oxo-M) is reduced when internal ATP is replaced by its nonhydrolyzable analogue AMP-PNP (Cruzblanca 2006) . Therefore, we asked whether ATP might also be required for I KV peptidergic modulation. Thus, cells were dialyzed for about 8 min with an internal solution containing AMP-PNP, instead of ATP. The Angio II-induced enhancement of I KV was remarkably reduced in the presence of this nonhydrolyzable nucleotide (Figure 4 ). In summary, Angio II enhanced I KV current density by 10.8 ± 2.2 pA/pF (n = 8) in ATP-dialyzed neurons, whereas this effect was reduced to 3.1 ± 1.5 pA/pF (n = 6) in those cells dialyzed with AMP-PNP.
FIGURE 4, HERE
Occlusion effects between Angio II and muscarinic agonists on I KV
The I KV enhancement by Angio II shows a strong parallelism with the muscarinic modulation of this delayed K + current (Cruzblanca 2006), namely both modulations are PTXinsensitive and disrupted by AMP-PNP. Therefore, it could be possible that the M 2/4 muscarinic and AT 1 receptors activate the same or similar signaling pathways to modulate I KV . This hypothesis was tested by bathing the cells sequentially with Angio II and Oxo-M, to look for additive or occlusive effects between these agonists. When Angio II was initially applied, there was an increase in I KV and upon reaching its maximum peptidergic stimulation Oxo-M had no effect on I KV ( Figure 5A , left plot). Likewise, when Oxo-M was first applied, it enhanced I KV amplitude thereafter an occlusion of the Angio II action occurred ( Figure 5A , right plot). In average, when Angio II (500 nM) and Oxo-M (1 µM) were applied alone ( Figure 5B , filled bars) the increment in I KV current density was 10.1 ± 2 pA/pF (n = 8) and 16 ± 1.4 pA/pF (n = 7), 12 respectively. Moreover, Angio II significantly reduced I KV enhancement by Oxo-M to 5.6 ± 1.5 pA/pF (n = 8), whereas Oxo-M practically occluded the Angio II effect (0.3 ± 0.2 pA/pF, n = 7) ( Figure 5B , open bars). Figure 6B ). In summary, PMA increased I KV current density by 10 ± 1.1 pA/pF (n= 7), whereas 4 -phorbol produced an increase of only 0.9 ± 0.5 pA/pF (n = 6) ( Figure 6C ). Furthermore, when cells were exposed only to Angio Page 12 of 37 13 II, this peptide enhanced I KV by 11.1 ± 1.4 pA/pF, (n=8), whereas in those cells previously treated with PMA the effect of Angio II was significantly (P < 0.05) reduced to 2.5 ± 1.2 pA/pF (n=7) ( Figure 6C ).
FIGURE 6, HERE
It is well known that sustained activation of PKC by PMA, which prolongs the association of PKC with the membrane, initiates the degradation of this protein kinase (Nishizuka 1988). Thus, to continue exploring the potential participation of PKC on I KV modulation, SCG neurons were incubated for 8 hrs with 30 nM PMA. Thereafter, PMA was removed from the culture medium before the patch-clamp experiments were carried out. It was found that long-term treatment with PMA reduced the Angio II-induced enhancement of I KV from 11.5 ± 1 pA/pF (n=7) to 3.8 ± 1.2 pA/pF (n=8), a difference statistically significant (P< 0.05). It has long been known that Angio II directly enhances sympathetic neuron excitability (Brown et al. 1980) . In SCG cells this effect is thought to be partially mediated by the inhibition of M-current, resulting in a slow depolarization, reduced spike threshold and reduced spike (nucleotides 1590-1610). The size of the amplified cDNA was 59 bp; rat G i1
